Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check6 days agoChange DetectedAccess to the study page now displays a 403 Forbidden error, replacing the usual study record content. The additions show the 403 message and related HTML headers, with navigation and study details no longer visible.SummaryDifference21%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now includes a grant/contract annotation '2015 ( U.S. NIH Grant/Contract )' and a new revision label 'Revision: v3.6.6', and it removes the previous revision label 'Revision: v3.6.5'.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing v3.6.4. This reflects a minor software update to the page without changes to visible content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe platform’s release version was updated from v3.6.3 to v3.6.4, indicating a minor software update. There is no indication that trial content or page data were changed.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small behind-the-scenes update to the page.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2. This update reflects internal version tracking rather than a change to page content.SummaryDifference0.0%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.